EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Luteolin attenuates CCl4-induced hepatic injury by inhibiting ferroptosis via SLC7A11

Zhiqiang Han, Batudeligen, Hongmei Chen, Narisu, Anda, Yanhua Xu, Lan Xue

BMC Complementary Medicine and Therapies · 16.05.2024 · 24 (1)

DOI: 10.1186/s12906-024-04486-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Complementary Medicine and Therapies, online erschienen am 16.05.2024. Verfasst von Zhiqiang Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology of Traditional Mongolian Medicine, Affiliated Hospital of Inner Mongolia Minzu University, No.1742, Huolinhe Stree…. Hauptthemen laut MEDLINE: Luteolin, Ferroptosis, Chemical and Drug Induced Liver Injury, Carbon Tetrachloride. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Young and Middle-aged Leading Talents Project Founding of Traditional Chinese Medicine (Mongolian Medicine) in Inner Mongolia Autonomous Region 2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Luteolin (3,4,5,7-tetrahydroxy flavone) is reported to strongly protect from acute carbon tetrachloride (CCl 4 ) -induced liver injury or fibrosis. Ferroptosis can be induced by hepatic injury, and contributes to liver fibrosis development. The exact functional mechanism underlying luteolin inhibition of hepatic injury and whether ferroptosis is involved are unclear.

Methods

Mice model and cell model of liver injury were constructed or induced to explore the effect and molecular mechanisms of Luteolin in the treatment of hepatic injury using CCl4. Cell Counting Kit-8 (CCK-8) and flow cytometry were used to evaluate HepG2 cell viability and apoptosis. The differential expressed genes involved in liver injury were scanned using RNA-seq and confirmed using functional study. Western blot was used to detect the indicators related to ferroptosis.

Results

Luteolin attenuated hepatic injury by alleviating cell morphology and decreasing serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) levels in vivo mice models, and increasing cell viability, downregulating arachidonate 12-lipoxygenase (ALOX12), cyclooxygenase-2 (COX-2) and P21 protein expression, suppressing apoptosis in vitro cell models. Luteolin also inhibited ferroptosis by stimulating glutathione peroxidase 4 (GPX4) and mitochondrial ferritin (FTMT) protein expression, increasing glutathione (GSH) content, and minimizing Fe 2+ and malondialdehyde (MDA) levels. Solute carrier family 7a member 11 (SLC7A11) was identified to be a key regulatory gene that participated in luteolin attenuation of CCl 4 -induced hepatic injuries in HepG2 cells using Microarray assay. Functional study showed that SLC7A11 can alleviate hepatic injury and ferroptosis.

Conclusion

Luteolin attenuated CCl 4 -induced hepatic injury by inhibiting ferroptosis via SLC7A11. SLC7A11 may serve as a novel alternative therapeutic target for hepatic injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinFerroptosisChemical and Drug Induced Liver InjuryCarbon TetrachlorideAmino Acid Transport System y+AnimalsMiceHumansHep G2 CellsMaleDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

FerroptosisGPX4Hepatic injuryLuteolinSLC7A11

Substanzen

LuteolinCarbon TetrachlorideAmino Acid Transport System y+Slc7a11 protein, mouseSLC7A11 protein, human

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology of Traditional Mongolian Medicine, Affiliated Hospital of Inner Mongolia Minzu University, No.1742, Huolinhe Street, Horqin Area, Tongliao City, Autonomous Region of Inner Mongolia, 02…

Förderung

  • National Natural Science Foundation of China
  • the Young and Middle-aged Leading Talents Project Founding of Traditional Chinese Medicine (Mongolian Medicine) in Inner Mongolia Autonomous Region 2022

Zitieren

APA

Han, Z., Batudeligen, Chen, H., Narisu, Anda, Xu, Y., & Xue, L. (2024). Luteolin attenuates CCl4-induced hepatic injury by inhibiting ferroptosis via SLC7A11. BMC Complementary Medicine and Therapies, 24(1). https://doi.org/10.1186/s12906-024-04486-2

Vancouver

Han Z, Batudeligen, Chen H, Narisu, Anda, Xu Y, et al. Luteolin attenuates CCl4-induced hepatic injury by inhibiting ferroptosis via SLC7A11. BMC Complementary Medicine and Therapies. 2024;24(1). doi:10.1186/s12906-024-04486-2

BibTeX
@article{Han2024,
  author = {Han, Zhiqiang and Batudeligen and Chen, Hongmei and Narisu and Anda and Xu, Yanhua and Xue, Lan},
  title = {Luteolin attenuates CCl4-induced hepatic injury by inhibiting ferroptosis via SLC7A11},
  journal = {BMC Complementary Medicine and Therapies},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12906-024-04486-2}
}
Kostenlos starten →